Aclaris Therapeutics, Inc. Profile Avatar - Palmy Investing

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research.

Medical - Diagnostics & Research
US, Wayne [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of ACRS's Analysis
CIK: 1557746 CUSIP: 00461U105 ISIN: US00461U1051 LEI: - UEI: -
Secondary Listings
ACRS has no secondary listings inside our databases.